Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up
Authors
Keywords
Liver Resection, Tace, Portal Hypertension, Major Hepatectomy, Future Liver Remnant
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 22, Issue 2, Pages 467-474
Publisher
Springer Nature
Online
2014-09-05
DOI
10.1245/s10434-014-4012-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Prior Hepatectomy on the Safety and Efficacy of Radioembolization With Yttrium-90 Microspheres for Patients With Unresectable Liver Tumors
- (2013) Lourens Bester et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?
- (2013) Julien Edeline et al. ANNALS OF SURGICAL ONCOLOGY
- Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma
- (2012) M. Iñarrairaegui et al. EJSO
- Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study
- (2012) Hojjat Ahmadzadehfar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic factors and prevention of radioembolization-induced liver disease
- (2012) Belen Gil-Alzugaray et al. HEPATOLOGY
- Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases
- (2012) Lai Mun Wang et al. JOURNAL OF CLINICAL PATHOLOGY
- Changes in Liver and Spleen Volumes and Liver Function after Radioembolization with Yttrium-90 Resin Microspheres
- (2011) John L. Nosher et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients
- (2010) Andrew S. Kennedy et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Factors Predicting Response and Survival After Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases
- (2010) Akshat Saxena et al. ANNALS OF SURGERY
- Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
- (2010) M Cosimelli et al. BRITISH JOURNAL OF CANCER
- Radioembolization (Yttrium-90 Microspheres) for Primary and Metastatic Hepatic Malignancies
- (2010) Andrew S. Kennedy et al. CANCER JOURNAL
- Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
- (2010) Alain Hendlisz et al. JOURNAL OF CLINICAL ONCOLOGY
- A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
- (2009) R. J. Lewandowski et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
- (2009) Riad Salem et al. GASTROENTEROLOGY
- Safety of Hepatic Resection in Metastatic Disease to the Liver After Yttrium-90 Therapy
- (2009) Ryan Whitney et al. JOURNAL OF SURGICAL RESEARCH
- Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections
- (2009) Seza A Gulec et al. World Journal of Surgical Oncology
- 90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors
- (2008) Thomas K. Rhee et al. ANNALS OF SURGERY
- Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
- (2008) Julie King et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now